Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
5 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Decoy Therapeutics Inc.’s names, not what it holds today.
Patents granted
5
4 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
1
Against none in 2024 and 2 in 2023
Applications published
10
3 of them in 2025
Names they are printed under
6
a former name, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
FLEX PHARMA, INC. a former name
named as the applicant on its applications, in US
5 publishedDecoy Therapeutics Inc. its own name
named as the applicant on its applications, in US
3 publishedFlex Pharma, Inc. a former name
US, as the owner printed on each patent
0 publishedSalarius Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
0 publishedSalarius Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
2 publishedDecoy Therapeutics Inc. its own name
US, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Feb 18, 2025 | 12,226,474 | Methods and compositions for treating infections | Pharmaceuticals | Decoy Therapeutics Inc. |
| Nov 21, 2023 | 11,820,720 | 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the same | Pharmaceuticals | Salarius Pharmaceuticals, Inc. |
| Oct 3, 2023 | 11,773,080 | Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same | Pharmaceuticals | Salarius Pharmaceuticals, Inc. |
| Oct 16, 2018 | D830,828 | Bottle | | Flex Pharma, Inc. |
| Apr 10, 2018 | 9,937,135 | Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise | Pharmaceuticals | Flex Pharma, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 25, 2025 | 2025/0387468 | Methods and Compositions for Treating Infections | Pharmaceuticals | Decoy Therapeutics Inc. |
| Dec 18, 2025 | 2025/0382240 | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Pharmaceuticals | Salarius Pharmaceuticals, Inc. |
| Oct 9, 2025 | 2025/0312330 | AMORPHOUS CABOZANTINIB PARTICLES AND USES THEREOF | Pharmaceuticals | FLEX PHARMA, INC. |
| Apr 4, 2024 | 2024/0108735 | METHODS AND COMPOSITIONS FOR TREATING COVID INFECTIONS | Pharmaceuticals | Decoy Therapeutics Inc. |
| Jul 28, 2022 | 2022/0233683 | METHODS AND COMPOSITIONS FOR TREATING INFECTIONS | Pharmaceuticals | Decoy Therapeutics Inc. · patent 12,226,474 granted from it |
| Feb 17, 2022 | 2022/0047528 | METHODS OF INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 (LSD-1) | Pharmaceuticals | Salarius Pharmaceuticals, Inc. |
| Feb 7, 2019 | 2019/0038573 | ION CHANNEL ACTIVATORS AND METHODS OF USE | Pharmaceuticals | FLEX PHARMA, INC. |
| May 3, 2018 | 2018/0116976 | METHODS AND COMPOSITIONS FOR UNWANTED OR ABNORMAL MUSCLE CONTRACTIONS | Pharmaceuticals | FLEX PHARMA, INC. |
| Feb 16, 2017 | 2017/0042834 | ION CHANNEL ACTIVATORS AND METHODS OF USE | Pharmaceuticals | FLEX PHARMA, INC. |
| Dec 22, 2016 | 2016/0367506 | METHODS OF TREATING MUSCLE CRAMPING AND RELATED COMPOSITIONS | Pharmaceuticals | FLEX PHARMA, INC. · patent 10,568,853 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 4.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.